Lotus Health — Clinical Intelligence Prototype

Attention

4

Patients deteriorating

Safety

2

High-risk reviews due

Measures

7

Outcome measures overdue

Stable

14

Patients clinically stable

Clinical attention queue

Patient	Trajectory	Key signal
Nomsa Dlamini MDD • PTSD	Deteriorating ↓	PHQ-9 12 → 19; passive SI
Thabo Molefe Bipolar I	Watch	Sleep 6.2h → 3.8h
Lerato Nkosi GAD	Improving ↑	GAD-7 16 → 8

Today

Safety: 2 patients require suicide-risk reassessment.

Monitoring: 3 metabolic screens are overdue.

Admin: 6 medical-aid motivations are due.

Discharge: 2 plans have incomplete readiness criteria.

Patient	Diagnosis	Last review	Trajectory	Risk
Nomsa Dlamini LH-00281	MDD, PTSD	28 Aug 2026	Deteriorating	Moderate
Thabo Molefe LH-00276	Bipolar I	01 Sep 2026	Watch	Low
Lerato Nkosi LH-00264	GAD	30 Aug 2026	Improving	Low

LIVE CONSULTATION

Nomsa Dlamini

42 years • MDD + PTSD • Last review 28 Aug 2026

NOTE SECTIONS

History of Presenting Illness

Structured prompts keep the note complete without forcing a rigid template.

Onset

Course

Duration

Functional impact

Clinical narrative

Mental State Examination

Fast structured MSE • searchable suggestions • optional free-text note

Predictive entry is operational. Type a letter or word and Lotus filters descriptors immediately. Press Enter for the first suggestion, click + to keep your own wording, or use Add comment to add clinical context.
Try: Objective Mood → E → Euthymic / Elevated.

● Predictive ON

1. Appearance & Behaviour 8 fields

Grooming / hygiene

Dress

Build / apparent health

Eye contact

Psychomotor activity

Abnormal movements

Rapport

Engagement

2. Speech 5 fields

Rate

Volume

Tone / prosody

Quantity

Spontaneity

3. Mood & Affect High-use

Mood — subjective

Mood — objective

Affect quality

Affect range

Reactivity

Congruence

Appropriateness

4. Thought Form Multi-select

Process

5. Thought Content & Safety Explicit

Preoccupations

Obsessions / compulsions

Delusions

Suicidal ideation

Self-harm ideation

Homicidal / violent ideation

6. Perception 4 fields

Hallucinations

Command hallucinations

Illusions

Depersonalisation / derealisation

7. Cognition Structured

Alertness

Orientation

Attention / concentration

Memory

Abstract thinking

MoCA

8. Insight Graded

Insight

9. Judgement 2 fields

Social judgement

Current situation

Risk synthesis: Complete the explicit safety fields above; Lotus will generate a concise stand-alone risk line here.

Risk Assessment

Safety signal: PHQ-9 item 9 / clinical history indicates suicidal ideation. Complete structured suicide assessment.

Suicidal ideation

Plan

Intent

Dynamic factors

Protective factors

Overall risk + rationale

Biopsychosocial 5P Formulation

Presenting

Predisposing

Precipitating

Perpetuating

Protective

Diagnosis

Diagnosis	Code	Status
Major depressive disorder	F32.2	Primary
Post-traumatic stress disorder	F43.1	Comorbid

Management Plan

Biological

Psychological

Social

Safety

Follow-up

MEASUREMENT-BASED CARE

Rating Scales

Suggested from today's presentation

PHQ-9
19 Severe range • ↑ from 12

C-SSRS
Recommended because suicidal ideation is documented.

GAD-7 14

PCL-5

WHODAS 2.0

Clinical Memory

Last visit

Sertraline increased to 100 mg. Initial PHQ-9 improvement 22 → 12. Sleep improved with trazodone. Divorce remains primary stressor.

Don't miss

• Passive SI
• Sleep deterioration
• Functional decline

Nomsa Dlamini

42 years • LH-00281 • MDD + PTSD • Last reviewed 28 Aug 2026

Trajectory: Deteriorating ↓ Risk: Moderate

Clinical Memory — “Brief me”

42-year-old woman with recurrent MDD and PTSD. Two previous psychiatric admissions. Sertraline was increased from 50 mg to 100 mg with initial improvement. PHQ-9 has subsequently increased from 12 to 19 alongside worsening insomnia and renewed passive suicidal ideation. Major current stressor: divorce proceedings.

Today's priorities: reassess suicidality, sleep, adherence, functional decline and treatment response.

Mental health timeline

05 SEP 2026

Risk signal

Passive SI reported; PHQ-9 increased to 19.

28 AUG 2026

Clinical review

Insomnia worsened; psychosocial stress increased.

12 JUL 2026

Medication change

Sertraline increased 50 mg → 100 mg.

18 JUN 2026

Outcome improvement

PHQ-9 22 → 12 after 8 weeks.

Trajectory

PHQ-9

19

12 → 19

Sleep

4.1h

↓ 1.6h

Function

45%

Declining

Safety intelligence

Dynamic risk increased.
Passive SI • hopelessness • insomnia • relationship breakdown

Protective factors

Children • therapeutic engagement • employed • family contact

Medication intelligence

Sertraline 100 mg mane	Initial response PHQ-9 22 → 12
Trazodone 100 mg nocte	Sleep response 3.2h → 5.7h

Outcome trajectory

Date	PHQ-9	GAD-7	Sleep
18 Jun	22	16	3.2h
12 Jul	16	12	4.8h
28 Aug	12	9	5.7h
05 Sep	19	14	4.1h

Record new measure

PHQ-9

GAD-7

Average sleep

Function

LOTUS SMART DOCUMENTATION

Nomsa Dlamini

Document once • reuse verified clinical information across downstream documents

1. Create document

Choose what Lotus should prepare from the clinical record.

Grounding rule
Lotus may summarise and reorganise the record, but should not create unsupported symptoms, findings, treatment response or history.

CLINICAL SOURCE MAP

2. What Lotus will use

8 sources available

Admission assessment
Severe depression • SI • insomnia • PHQ-9 23 Progress notes ×4
Treatment response and interval changes Medication history
Sertraline 50 → 100 mg; trazodone Rating-scale trajectory
PHQ-9 23 → 17 → 12

Latest MSE
Dysphoric affect • improving risk profile Risk assessments
Passive SI → no active SI Care / management plan
CBT • medication optimisation • safety planning Discharge planning
Readiness documented; follow-up incomplete

Completeness check: Follow-up appointment details are not yet documented. Lotus will not invent them.

PURPOSE-AWARE SUMMARY

Select a document

Lotus will prioritise different clinical facts depending on the document's purpose rather than generating the same generic summary every time.

Choose a document on the left, review the source material above, then generate a grounded draft.

Draft remains editable. Final responsibility and sign-off remain with the clinician.

Clinical provenance

See why each statement appears in the document.

Admission Severe depressive presentation and baseline PHQ-9.

Medication Sertraline dose optimisation.

Progress Partial then progressive response.

Risk Change in suicidal ideation.

Document history

Document	Status
Continued stay • Day 10	Signed
Medical-aid motivation	Submitted
Discharge summary	Not created

Due

6

Motivations due

Review

2

Authorisations to check

Risk

1

Submission warning

30 days

88%

First-submission approval

Lotus Funder Intelligence

Continued-Care Motivation Assistant

Clinical record → scheme-ready motivation → validation → clinician sign-off

Patient

Medical scheme

Care setting

Request

Form

Requested care

Pulled from the EHR

Diagnosis	MDD, severe; PTSD
Symptoms	Low mood, hopelessness, insomnia, passive SI
Medication	Sertraline 100 mg; Trazodone 100 mg nocte
Response	Partial response; recent deterioration
Therapy	CBT / trauma-focused therapy ongoing
Function	Significantly impaired

Pre-submission checker

Submission readiness76%

✓ Diagnosis documented

✓ Medication documented

✓ Treatment response documented

✓ Functional impairment documented

Review: suicide-risk reassessment requires updating.

Missing: explicit discharge barriers / why lower level of care is not yet appropriate.

Authorisation integrity

Authorisation number

Validation: compare with active admission episode and previous submissions.

Generated motivation — clinician review

Click “Generate motivation” to create a draft from the patient's existing clinical record.

Funder history

Scheme	Request	Outcome
Discovery	7-day extension	Approved
Bonitas	Continued stay	More info
GEMS	Outpatient extension	Approved

Active patients

624

Improving

71%

Stable

18%

Deteriorating

11%

Practice outcomes

Median PHQ-9 improvement	8 points
30-day readmission	7.2%
Return-to-work documented	68%
Outcome measure completion	82%

Value proposition

This screen demonstrates the future B2B layer: practices, hospitals and funders can evaluate measurable mental-health outcomes rather than relying only on consultation counts and claims activity.

Clinical Command Centre